Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 1, 2007, Pages 38-41

  Abrahamian, H ^b,d   Endler, G ^a   Exner, M ^a   Mauler, H ^b   Raith, M ^a   Endler, L ^a   Rumpold, H ^a   Gerdov, M ^a   Mannhalter, C ^a   Prager, R ^b   Irsigler, K ^c   Wagner, O F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

^c Ludwig Boltzmann Society for Clinical and Experimental Oncology   (Austria)

^d City Hospital Vienna Lainz   (Austria)

Author keywords

Diabetes type 2; Diabetic nephropathy; Low grade inflammation; Proinflammatory polymorphisms

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN A1C; INTERLEUKIN 1 RECEPTOR AFFECTING AGENT; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; DNA POLYMORPHISM; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

AGED; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 33847094658     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-948213     Document Type: Article

References (21)

1. Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-374
2. Du Clos TW: Function of C-reactive protein. Ann Med 2000; 32: 274-278
3. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58: 1703-1710
4. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376
5. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM et al.: C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 2002; 22: 593-598
6. Kamiuchi K, Hasegawa G, Obayashi H, Kitamura A, Ishii M, Yano M: Leukocyte- endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complications 2002; 16: 333-337
7. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Finnish Diabetes Prevention Study, et al.: Promoter polymorphisms of the TNF-alpha (G-308A) and IL (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 2003; 52: 1872-1876
8. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M: Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 2004; 112: 378-382
9. Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E: Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 2002; 51: 3582-3585
10. Navarro JF, Mora C, Maca M, Garca J: Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003; 42: 53-61
11. Ortega O, Rodriguez I, Gallar P, Carreno A, Ortiz M, Espejo B, Jimenez J, Gutierrez M, Oliet A, Vigil A: Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant 2002; 17: 1105-1109
12. Otto C, Engelschalk C, Fraunberger P, Laubach E, Schwandt P: Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes. Acta Diabetol 2001; 38: 153-155
13. Remuzzi G, Schieppati A, Ruggenenti P: Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-1151
14. Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH and the FinnDiane Study Group.: Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 2003; 46: 1402-1407
15. Schwedler S, Guderian F, Dämmrich J, Lawrence AP, Wanner CH: Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol Dial Transplant 2003; 18: 2300-2307
16. Singleton JR, Smith AG, Russell JW, Feldmann EL: Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867-2873
17. Solini A, Dalla Vestra M, Saller A, Nosadini R, Crepaldi G, Fioretto P: The angiotensin- converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51: 251-255
18. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes 2002; 51: 1157-1165
19. Streja D, Cressey P, Rabkin SW: Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. J Diabetes Complications 2003; 17: 120-127
20. Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y: Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 2001; 24: 1653-1660
21. Yue DK, McLennan SV, Turtle JR: Pathogenesis of diabetic microangiopathy: the roles of endothelial cell and basement membrane abnormalities. Diabet Med 1992; 9: 218-223